Drug intelligence / Profile preview

Evolve34

Development stage: Unknown
Lead developer: MedShape

Overview

Evolve34 is a dietary supplement marketed for weight management and metabolic support. It is typically formulated as a multi-ingredient product containing various botanical extracts, vitamins, and minerals intended to enhance energy levels and promote fat oxidation. While specific formulations may vary by manufacturer, the product is generally positioned within the nutraceutical market as a non-pharmaceutical intervention for individuals seeking to support their weight loss goals through dietary supplementation. It is not an FDA-approved pharmaceutical drug for the treatment of obesity or any medical condition.

Brand names: Evolve34Evolve-34Evolve 34
Other names: Evolve34Evolve-34Evolve 34

Beyond the preview

Go deeper on Evolve34.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evolve34.

Explore the full profile